Consolidation treatment with Yttrium-90 ibritumomab tiuxetan after new induction regimen in patients with intermediate- and high-risk follicular lymphoma according to the follicular lymphoma international prognostic index: A multicenter, prospective phase II trial of the Spanish Lymphoma Oncology Group

  1. Provencio, M. 1
  2. Cruz Mora, M.A. 2
  3. Gómez-Codina, J. 3
  4. Quero Blanco, C. 4
  5. Llanos, M. 5
  6. García-Arroyo, F.R. 6
  7. De La Cruz, L. 7
  8. Gumá Padró, J. 8
  9. Delgado Pérez, J.R. 9
  10. Sánchez, A. 1
  11. Álvarez Cabellos, R. 2
  12. Rueda, A. 10
  1. 1 Hospital Universitario Puerta de Hierro
    info

    Hospital Universitario Puerta de Hierro

    Madrid, España

    ROR https://ror.org/01e57nb43

  2. 2 Hospital Universitario de Toledo
  3. 3 Hospital Universitario La Fe
    info

    Hospital Universitario La Fe

    Valencia, España

    ROR https://ror.org/01ar2v535

  4. 4 Hospital Clínico de Málaga
  5. 5 Hospital Universitario de Canarias
    info

    Hospital Universitario de Canarias

    San Cristóbal de La Laguna, España

    ROR https://ror.org/05qndj312

  6. 6 Hospital Universitario Pontevedra
  7. 7 Hospital Universitario Virgen Macarena
    info

    Hospital Universitario Virgen Macarena

    Sevilla, España

    ROR https://ror.org/016p83279

  8. 8 Hospital Universitari Sant Joan de Reus
    info

    Hospital Universitari Sant Joan de Reus

    Reus, España

    ROR https://ror.org/04f7pyb58

  9. 9 Hospital Universitario Virgen de las Nieves
    info

    Hospital Universitario Virgen de las Nieves

    Granada, España

    ROR https://ror.org/02f01mz90

  10. 10 Hospital Costa Del Sol
    info

    Hospital Costa Del Sol

    Marbella, España

    ROR https://ror.org/0065mvt73

Journal:
Leukemia and Lymphoma

ISSN: 1042-8194

Year of publication: 2014

Volume: 55

Issue: 1

Pages: 51-55

Type: Article

DOI: 10.3109/10428194.2013.790544 PMID: 23573825 SCOPUS: 2-s2.0-84891354429 GOOGLE SCHOLAR
Data source: Scopus